CHO cell CRISPR Engineering for enhancing HIV-1 vaccine effi

This article describes the role of CHO cell CRISPR in engineering the HIV-1 Vaccine with higher efficacy, enabling the rapid generation of an MGAT1-deficient CHO cell line.

Related Keywords

China , Chinese , Maria Osipova , Maxcyte Inc Aug , University Of California Santa Cruz , Maxcyte Inc , Sponsored Content , Inc Aug , Chinese Hamster Ovary , California Santa Cruz , Creative Commons License Attribution , Maxcyte Electroporation Buffer , Image Credit , Glycan Dependent Epitopes Are Frequently Targeted , Broad Neutralizing Antibody Responses , Trial Improve Binding , Broadly Neutralizing , Flow Electroporation , Content Policy , News Medical Net , Cho Cell Crispr , Iv 1 Vaccine Efficacy , Fell , Begat , ,